Cycloset

 

Brand Name (Generic Name)

Cycloset (Bromocriptine)

Bromocriptine is the first-of-its-kind drug that increases dopamine in the brain in order to improve blood sugar control in people with type 2 diabetes. It has a rather weak blood sugar-lowering capability. Although the mechansim of action is not clear, it may centrally reverse many of the metabolic changes that are associated with insulin resistance and obesity.

Who can take Cycloset?

Selected patients with type 2 diabetes.

Who should not take Cycloset?

People with type 1 diabetes, ketoacidosis, or sensitvity to ingredients.

How is Cycloset taken?

Cycloset is taken once a day. The dose varies as tolerated up to 4.8 mg daily. It is taken within two hours of waking up and with food.

What are possible side effects?

Low blood pressure (hypotension), fainting, gastrointestinal symptoms, headache, dizziness, and weakness. Use may exacerbate psychotic disorders or reduce the effectiveness of drugs that treat psychosis.

Are other diabetes medicines used with Cycloset?

Should be used in combination with diet and exercise. Limited efficacy data in combination with thiazolidinediones. Efficacy has not been confirmed in combination with insulin.

Reviewed by James A. Bennett 05/13

Last Modified Date: May 28, 2013

All content on dLife.com is created and reviewed in compliance with our editorial policy.

More on this Topic

No items are associated with this tag

Sign up for FREE dLife Newsletters

dLife Membership is FREE! Get exclusive access, free recipes, newsletters, savings, and much more! FPO

Congratulations!
You are subscribed!
Congratulations!
You are subscribed!
Congratulations!
You are subscribed!
126 Views 0 comments
by Brenda Bell
Most of the time, we bash the lastest news about a "diabetes cure" because it is neither a cure, nor often even a significant improvement in diabetes treatment. Usually these "cures" are tested in mice, but fail to make the leap over to human physiology. Devices may work in the lab, but take decades to pass through FDA review, and still not be much better than what we already have. It's enough to make us all jaded. I know I am. But I saw something...